CHIAPPALUPI, SARA
 Distribuzione geografica
Continente #
NA - Nord America 2.341
AS - Asia 1.695
EU - Europa 1.601
SA - Sud America 336
Continente sconosciuto - Info sul continente non disponibili 179
AF - Africa 58
OC - Oceania 11
Totale 6.221
Nazione #
US - Stati Uniti d'America 2.255
SG - Singapore 744
IT - Italia 613
BR - Brasile 271
CN - Cina 246
IE - Irlanda 206
HK - Hong Kong 203
RU - Federazione Russa 156
DE - Germania 112
VN - Vietnam 97
KR - Corea 90
FR - Francia 89
BD - Bangladesh 62
SE - Svezia 61
GB - Regno Unito 57
NL - Olanda 56
IN - India 50
FI - Finlandia 48
CA - Canada 42
RO - Romania 40
AT - Austria 32
UA - Ucraina 32
PH - Filippine 27
JP - Giappone 26
TR - Turchia 26
IQ - Iraq 25
MX - Messico 24
ZA - Sudafrica 21
PL - Polonia 19
CO - Colombia 18
ES - Italia 18
BE - Belgio 15
PK - Pakistan 14
AR - Argentina 13
CH - Svizzera 10
EC - Ecuador 10
SA - Arabia Saudita 10
UZ - Uzbekistan 9
AU - Australia 8
ID - Indonesia 8
MA - Marocco 7
PY - Paraguay 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
IR - Iran 6
TN - Tunisia 6
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
IL - Israele 5
LB - Libano 5
MD - Moldavia 5
TW - Taiwan 5
VE - Venezuela 5
AL - Albania 4
EG - Egitto 4
JM - Giamaica 4
JO - Giordania 4
KH - Cambogia 4
LT - Lituania 4
MY - Malesia 4
BA - Bosnia-Erzegovina 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
GR - Grecia 3
HU - Ungheria 3
KZ - Kazakistan 3
NZ - Nuova Zelanda 3
OM - Oman 3
PA - Panama 3
PE - Perù 3
UY - Uruguay 3
BY - Bielorussia 2
DZ - Algeria 2
EU - Europa 2
GE - Georgia 2
KE - Kenya 2
KG - Kirghizistan 2
NI - Nicaragua 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TZ - Tanzania 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
BB - Barbados 1
CV - Capo Verde 1
DJ - Gibuti 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
IS - Islanda 1
LV - Lettonia 1
ML - Mali 1
MR - Mauritania 1
MU - Mauritius 1
MW - Malawi 1
NG - Nigeria 1
NO - Norvegia 1
Totale 6.040
Città #
Singapore 576
Chandler 253
San Jose 235
Dublin 202
Perugia 196
Hong Kong 192
Ashburn 161
Santa Clara 92
San Mateo 89
Boardman 77
Moscow 67
The Dalles 62
Beijing 58
Los Angeles 57
Lauterbourg 51
Dearborn 44
Redmond 44
New York 42
Medford 41
Altamura 40
Ann Arbor 40
Munich 40
Princeton 40
Wilmington 38
Seoul 36
Bucharest 34
Ho Chi Minh City 30
Turin 29
Bologna 28
São Paulo 28
Vienna 28
Andover 26
Lawrence 23
Falls Church 19
Seongnam-si 19
Montreal 18
Piscataway 18
Tokyo 18
Orem 17
Hanoi 16
Brussels 15
Milan 15
Phoenix 15
Amsterdam 14
Dallas 14
Johannesburg 14
Brooklyn 13
Cebu City 13
Falkenstein 13
Boston 12
Denver 12
Norwalk 12
Rome 12
Atlanta 11
Helsinki 11
London 11
Nuremberg 11
Warsaw 11
Council Bluffs 10
Houston 10
Jacksonville 10
Saint Petersburg 10
Turku 10
Baghdad 9
Parma 9
Redwood City 9
San Francisco 9
Brasília 8
Da Nang 8
Frankfurt am Main 8
Groningen 8
Istanbul 8
Mumbai 8
Tijuana 8
Toronto 8
Chennai 7
Columbus 7
Dhaka 7
Florence 7
Hefei 7
Rio de Janeiro 7
Shanghai 7
Stockholm 7
Buffalo 6
Collazzone 6
Des Moines 6
Glasgow 6
Incheon 6
Naples 6
Tashkent 6
Trinity 6
Baku 5
Belo Horizonte 5
Dong Ket 5
Jakarta 5
Lahore 5
Lappeenranta 5
Mexico City 5
Ottawa 5
Paris 5
Totale 3.652
Nome #
Beneficial effects of horsetail (Equisetum arvense) in experimental models of sarcopenia and osteoporosis 284
Pharmacological targeting of the receptor for advanced glycation end-products (RAGE) to counteract cancer cachexia 200
Intraperitoneal injection of microencapsulated Sertoli cells restores muscle morphology and performance in dystrophic mice 176
Histological muscle characterization in hypertrophied Marchigiana cattle breed 176
IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII 161
Targeting RAGE prevents muscle wasting and prolongs survival in cancer cachexia 153
Identification of natural products able to counteract the formation of advanced glycation end-products (AGEs) sustaining muscle atrophy 152
RAGE in the pathophysiology of skeletal muscle. 148
S100B protein regulates myoblast and macrophage functions in skeletal muscle regeneration 142
Equisetum arvense standardized extract hinders age-related sarcopenia 141
Generation of an mdx/Ager–/– double mutant mouse. Preliminary data on skeletal muscle architecture. 141
Absence of RAGE in an animal experimental model of Duchenne muscular dystrophy results in reduced muscle necrosis and inflammation 140
Sertoli cells protect C2C12 myotubes against atrophy and induce utrophin expression in canine and human dystrophic myotubes. 137
Toward the identification of receptor for advanced glycation end-products (RAGE) as a muscle biomarker of cancer cachexia. 137
Natural products to counteract muscle atrophy 135
Ablation of RAGE (receptor for advanced glycation end-products) translates into reduced tumorigenic and cachectic potential in LLC-tumor bearing mice 133
Sertoli cell-secreted factors have promyogenic and antifibrotic properties on human DMD myoblasts with different mutations. 131
Effects of intraperitoneal injection of microencapsulated Sertoli cells on chronic and presymptomatic dystrophic mice 129
RAGE and its ligands, S100B and HMGB1, are molecular determinants of cancer-induced muscle wasting. 127
Targeting RAGE as a potential therapeutic approach to Duchenne muscular dystrophy 125
Involvement of a RAGE/p38MAPK/myogenin axis in cancer cachexia. 113
Mdx/Ager–/– mice show reduced muscle necrosis and inflammation compared with mdx mice 110
The effects of microgravity on human skeletal muscle regeneration. 109
KYMASIN UP Natural Product Inhibits Osteoclastogenesis and Improves Osteoblast Activity by Modulating Src and p38 MAPK 108
Beneficial effects of horsetail (Equisetum arvense) in in vitro models of sarcopenia and osteoporosis 108
Receptor for advanced glycation end-products (RAGE) as a biomarker of muscle wasting in cancer conditions 108
Microencapsulated Sertoli cells sustain myoblast proliferation without affecting the myogenic potential. In vitro data 108
Employment of Microencapsulated Sertoli Cells as a New Tool to Treat Duchenne Muscular Dystrophy 107
Transplantation of microencapsulated Sertoli cells: a new potential antiinflammatory approach to Duchenne muscular dystrophy (DMD). 106
Identification of Withania somnifera-Silybum marianum-Trigonella foenum-graecum Formulation as a Nutritional Supplement to Contrast Muscle Atrophy and Sarcopenia 105
Hyperactivated rage in comorbidities as a risk factor for severe covid-19—the role of rage-ras crosstalk 105
Equisetum arvense standardized dried extract hinders age-related osteosarcopenia. 103
Do porcine Sertoli cells represent an opportunity for Duchenne muscular dystrophy? 101
Levels of S100B protein drive the reparative process in acute muscle injury and muscular dystrophy 100
Use of Sertoli cells to treat DMD patients is supported by their immunomodulatory rather than immunosuppressive effect 99
Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness 98
Novel data support the use of microencapsulated Sertoli cells as a potential treatment of DMD patients. 96
Reductive stress in striated muscle cells 96
S100 proteins in obesity: liaisons dangereuses 95
The receptor RAGE: a potential molecular target in cancer cachexia 94
HEREGULIN-INDUCED UTROPHIN UPREGULATION PROMOTES RECOVERY OF MUSCLE HOMEOSTASIS IN MDX MICE TRANSPLANTED WITH MICROENAPSULATED SERTOLI CELLS 92
Transplantation of microencapsulated Sertoli cells in mdx mice reduces muscle inflammation and promotes muscle regeneration 92
Sertoli cells induce utrophin expression in human DMD myotubes with different mutations and exert promyogenic and antifibrotic effects 91
RAGE expression in rhabdomyosarcoma cells modulates metastasis formation in vivo. 91
Transplantation of microencapsulated Sertoli cells in a mouse model of Duchenne muscular dystrophy (DMD) reduces inflammation and rescues muscle performance. 88
Self-powered temperature sensors harnessing membrane potential of living cells 76
The novel DMD experimental model, mdx/Ager–/– mouse reveals a role of RAGE in inflammatory processes in dystrophic muscles. 76
Grafted Sertoli Cells Exert Immunomodulatory Non-Immunosuppressive Effects in Preclinical Models of Infection and Cancer 75
Targeting RAGE to prevent SARS-CoV-2-mediated multiple organ failure: Hypotheses and perspectives 70
Sertoli cells improve myogenic differentiation, reduce fibrogenic markers, and induce utrophin expression in human dmd myoblasts 70
Intraperitoneal transplantation of microencapsulated Sertoli cells counteracts muscle inflammation and rescues muscle performance in mdx mice. 68
The MyoGravity project to study real microgravity effects on human muscle precursor cells and tissue 61
Preparation of Human Muscle Precursor Cells for the MyoGravity Project - Cell Culture in Experiment Units for Space Flight Purpose 58
Sertoli cells have promyogenic and antifibrotic effects, and induce utrophin expression in human DMD myotubes with different mutations in a heregulin β1/ErbB2/ERK1/2-dependent manner 54
Diet-Derived Advanced Glycation End-Products (AGEs) Induce Muscle Wasting In Vitro, and a Standardized Vaccinium macrocarpon Extract Restrains AGE Formation and AGE-Dependent C2C12 Myotube Atrophy 17
RAGE Re-Expressed at Myofibre Level Drives Muscle Wasting in Cancer Conditions 5
Totale 6.221
Categoria #
all - tutte 24.894
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.894


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022416 0 65 9 19 12 12 12 106 12 39 58 72
2022/2023717 43 128 5 64 60 77 1 34 269 2 27 7
2023/2024387 18 28 9 35 18 12 102 8 19 24 37 77
2024/20251.448 46 103 148 84 166 68 136 153 195 87 186 76
2025/20262.375 140 116 96 276 308 206 384 155 229 195 211 59
2026/2027226 166 60 0 0 0 0 0 0 0 0 0 0
Totale 6.221